Clinithink’s AI technology, capable of reading and understanding medical records, has been used successfully by a research team at Barts Health NHS Trust to predict which patients might be at risk of lung cancer in a first-of-its-kind project funded by AstraZeneca. Data presented at the American Society of Clinical Oncology (ASCO) congress showcased how Clinithink’s AI technology has been used by the trust to build a predictive algorithm which can identify patients at a higher risk of lung cancer. The study processed over 75,000 historical patient records to build an algorithm that could predict which patients were more likely to have had lung cancer with greater accuracy than existing risk factor assessment tools used for cancer detection in the NHS. … Continue reading AI could predict risk of lung cancer at an earlier stage, new research shows